Kezar Life Sciences, Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kezar Life Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Kezar Life Sciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$21.9M, a 14% increase year-over-year.
  • Kezar Life Sciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$104M, a 6.98% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Operating Income (Loss) for 2023 was -$111M, a 56.6% decline from 2022.
  • Kezar Life Sciences, Inc. annual Operating Income (Loss) for 2022 was -$71.2M, a 30.2% decline from 2021.
  • Kezar Life Sciences, Inc. annual Operating Income (Loss) for 2021 was -$54.7M, a 27.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$111M -$40.3M -56.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$71.2M -$16.5M -30.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$54.7M -$11.7M -27.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$43M -$5.61M -15% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 -$37.3M -$12.6M -51% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 -$24.7M -$16M -183% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 -$8.75M +$241K +2.68% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$8.99M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.